Sarah Howell
Chief Executive Officer at ARECOR THERAPEUTICS PLC
Net worth: 1 M $ as of 29/04/2024
Sarah Howell active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ARECOR THERAPEUTICS PLC | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| Investor Relations Contact | - | - | |
| Chief Operating Officer | - | - | |
Arecor Ltd.
 Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Director/Board Member | 09/11/2011 | - |
| Chief Executive Officer | 31/12/2014 | - | |
| Chief Operating Officer | 09/11/2011 | 31/12/2014 |
Career history of Sarah Howell
Former positions of Sarah Howell
Training of Sarah Howell
| University of St. Andrews | Doctorate Degree |
| University of Birmingham | Undergraduate Degree |
Statistics
International
| United Kingdom | 7 |
| Belgium | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| UCB | Health Technology |
| GSK PLC | Health Technology |
| ARECOR THERAPEUTICS PLC | Health Technology |
| Private companies | 2 |
|---|---|
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Sarah Howell
- Experience
